Related Experiment Videos

[Direct percutaneous transluminal coronary angioplasty]

R Ilia1, A Abu-Ful, S Carmel

  • 1Cardiology Division, Soroka Medical Center, Beer Sheba.

Harefuah
|March 15, 1996
PubMed

Insights

Direct percutaneous transluminal coronary angioplasty (PTCA) is a safe and effective reperfusion strategy for acute myocardial infarction (AMI). This procedure demonstrates high success rates, comparable to elective PTCA, with minimal complications.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Early reperfusion significantly reduces mortality in acute myocardial infarction (AMI).
  • Direct percutaneous transluminal coronary angioplasty (PTCA) is an alternative to thrombolytic therapy for early AMI.

Purpose of the Study:

  • To evaluate the safety and efficacy of direct PTCA in patients with acute myocardial infarction.
  • To assess the success rate of direct PTCA in achieving coronary artery reperfusion.

Main Methods:

  • Retrospective analysis of 289 PTCA procedures over one year.
  • Identified 29 direct PTCA cases (10%) for analysis.
  • Recorded indications, target vessels, procedural success, and complications.

Main Results:

  • Direct PTCA was performed in 29 patients, with indications including large infarcts (72%) and cardiogenic shock (28%).
  • Successful reperfusion was achieved in 90% of cases; 7% had partial success, and 3% failed.
  • No major complications were reported; 4 patients required stent deployment for dissection.

Conclusions:

  • Direct PTCA is a safe and effective reperfusion strategy for acute myocardial infarction.
  • The success rate of direct PTCA in AMI is comparable to elective PTCA.
  • High rates of successful reperfusion can be achieved with direct PTCA in AMI.

Related Concept Videos